How Mission Bio is working to drive precision medicine

In an interview with Drug Discovery & Development, Mission Bio CEO Yan Zhang discussed how the Tapestri Platform can help drug developers accelerate timelines while helping the CGT industry redefine safety, dosing and long-term efficacy.